Patents by Inventor Christian De Muynck

Christian De Muynck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10252014
    Abstract: A device and system for delivering an aerosol to a patient on ventilatory support comprise a contact component 10 to be positioned in contact with a respiratory organ. The contact component 10 comprises a lumen 18a, 20a, 24 through which breathing gas and an aerosol are delivered to lungs of a patient.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: April 9, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Daniela Rahmel, Friedemann Taut, Christian De Muynck, Peter Iwatschenko, Wolfgang Koch, Gerhard Pohlmann, Horst Windt
  • Patent number: 9833410
    Abstract: The present invention relates to aqueous formulations comprising at least 20 mg/ml of a compound neutralizing GM-CSF, a lyoprotectant and an amino acid and/or a buffer. The ingredients of the formulation preferably provide stability to the compound neutralizing GM-CSF in view of lyophilization, storage and reconstruction. In a preferred aspect, the formulation, e.g. after reconstruction, is for use in therapy, preferably for use in the treatment of inflammatory and autoimmune disorders, preferably including allergic and psoriatic disorders, as well as arthritic and asthmatic disorders. Furthermore, a kit comprising the formulation of the invention is provided.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: December 5, 2017
    Assignees: Takeda GmbH, Amgen Research (Munich) GmbH
    Inventors: Markus Rast, Wolfram Steinhilber, Christian de Muynck, Gerhard Becker, Pernille Dybendal Pedersen, Thomas Urbig, Thomas Boehm
  • Patent number: 9693955
    Abstract: The invention relates to aerosolized and humidified particles comprising a therapeutically active substance which can be obtained by suspending dry inhalable particles in a carrier gas, adding water vapor and causing condensation of water on the particles. The invention further relates to methods to generate these particles, and apparatus useful to carry out such methods.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: July 4, 2017
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Daniela Rahmel, Friedemann Taut, Christian De Muynck, Markus Rast, Peter Iwatschenko, Gerhard Pohlmann, Wolfgang Koch, Horst Windt
  • Publication number: 20150342888
    Abstract: The present invention relates to aqueous formulations comprising at least 20 mg/ml of a compound neutralizing GM-CSF, a lyoprotectant and an amino acid and/or a buffer. The ingredients of the formulation preferably provide stability to the compound neutralizing GM-CSF in view of lyophilisation, storage and reconstruction. In a preferred aspect, the formulation, e.g. after reconstruction, is for use in therapy, preferably for use in the treatment of inflammatory and autoimmune disorders, preferably including allergic and psoriatic disorders, as well as arthritic and asthmatic disorders. Furthermore, a kit comprising the formulation of the invention is provided.
    Type: Application
    Filed: October 31, 2013
    Publication date: December 3, 2015
    Inventors: Markus Rast, Wolfram Steinhilber, Christian de Muynck, Gerhard Becker, Pernille Dybendal Pedersen, Thomas Urbig, Thomas Boehm
  • Publication number: 20130152925
    Abstract: A device and system for delivering an aerosol to a patient on ventilatory support comprise a contact component 10 to be positioned in contact with a respiratory organ. The contact component 10 comprises a lumen 18a, 20a, 24 through which breathing gas and an aerosol are delivered to lungs of a patient.
    Type: Application
    Filed: August 8, 2011
    Publication date: June 20, 2013
    Applicant: TAKEDA GMBH
    Inventors: Daniela Rahmel, Friedemann Taut, Christian De Muynck, Peter Iwatschenko, Wolfgang Koch, Gerhard Pohlmann, Horst Windt
  • Publication number: 20130142782
    Abstract: The invention relates to aerosolized and humidified particles comprising a therapeutically active substance which can be obtained by suspending dry inhalable particles in a carrier gas, adding water vapor and causing condensation of water on the particles. The invention further relates to methods to generate these particles, and apparatus useful to carry out such methods.
    Type: Application
    Filed: August 22, 2011
    Publication date: June 6, 2013
    Applicant: TAKEDA GMBH
    Inventors: Daniela Rahmel, Friedemann Taut, Christian De Muynck, Markus Rast, Peter Iwatschenko, Gerhard Pohlmann, Wolfgang Koch, Horst Windt